To evaluate the safety and efficacy of Unani medicines( Karafas and Duqu) in the management of Urolithiasis.

To Evaluate the efficacy of Unani medicines Tukhm-e-Karafs(Apium graveolans Linn)and Tukhm-e-Duqu (Peucedanum grande C.B.Clarke) in the management of Sangi Gurda wa Masana(Urolithiasis) in a clinical study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009407

Enrollment

Registered

2017-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hasal al Kulya wa Masana(Urolithiasis)

Interventions

Intervention1: Unani medicine Tukhmi Karafas and Tukhmi Duqu: 4gm in two divided doses for 06 weeks Intervention2: nil: nil Control Intervention1: Nil: NIl

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with established Sangi Gurda wa Masana (Urolithiasis) proved by radiological or sonological investigations. 2.Hematologic and Biochemical parameters within normal limits. 3.Patients with normal liver and kidney function. 3.Patients willing to continue whole period of trial with their written consent.

Exclusion criteria

Exclusion criteria: 1.Patients with impaired liver and kidney function. 2.Patients with urolithiasis causing obstruction needing emergency management. 3.Patients already on some medication for urolithiasis. 4.Pregnant and lactating women. 5.Patients unwilling to provide informed consent or abide by the requirements of the study

Design outcomes

Primary

Measure	Time frame
Symptomatic relief from clinical symptoms of urolithiasisTimepoint: 06 weeks	—

Secondary

Measure	Time frame
Reduction in size of stone or expulsion of stone by viewing ultrasonological impression.Timepoint: 06 weeks	—

Countries

India

Contacts

Public ContactDr Mohd Rafi Thoker

Govt. Nizamia Tibbi College Charminar Hyderabad

drmeer07@yahoo.com9848089126

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026